Drug intelligence / Profile preview

Duramune

Development stage
Unknown
Lead developer
Elanco
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Duramune is a veterinary vaccine line used primarily for the immunization of dogs against several major canine viral diseases. The most common formulations are combination vaccines containing modified live viruses for canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. Some formulations also include killed or inactivated components such as canine coronavirus. The vaccine stimulates active immunity by exposing the animal’s immune system to antigens from these pathogens without causing disease. It is indicated for healthy dogs six weeks of age or older and is administered via subcutaneous injection[1][3][4].

Brand names
DuramuneDuramune Max 5ULTRA Duramune DAPDuramune Puppy DP + CDuramune Max 5-CvK
Other names
TruCan DAPPiTruCan DAPPi+C

Beyond the preview

Go deeper on Duramune.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duramune.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call